Jacobs Levy Equity Management, Inc Shattuck Labs, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 85,638 shares of STTK stock, worth $63,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,638Holding current value
$63,372% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding STTK
# of Institutions
76Shares Held
30.9MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$4.91 Million2.25% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$4.1 Million0.55% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$3.46 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$1.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$1.78 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $31.4M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...